Literature DB >> 35040790

Hepatitis E Infection in Solid Organ Transplant Recipients in Turkey.

Seval Öğüt1, Ayça Arzu Sayıner1, Barış Otlu2, Gülendam Bozdayı3, Ayşın Zeytinoğlu4, Sebahat Aksaray5, Dilek Çolak6, Selma Gökahmetoğlu7, Murat Aysın8.   

Abstract

BACKGROUND: Hepatitis E virus is a re-emerging pathogen with an increase in human cases that can lead to chronic infection in immunosuppressed patients. Turkey is located between Asia and Europe, 2 regions with distinct epidemiological and clinical features of hepatitis E virus infection. This multicenter cross-sectional study aimed to investigate the prevalence of hepatitis E virus infection in liver and kidney transplant recipients in Turkey and to determine the role of possible transmission factors.
METHODS: A total of 485 plasma samples of solid organ recipients were collected from 7 transplantation centers in Turkey. Samples were tested for anti-hepatitis E virus immunoglobin M, immunoglobin G, and hepatitis E virus ribonucleic acid. Water- and food-related risk factors were evaluated by a questionnaire.
RESULTS: Samples of 300 kidney and 185 liver recipients were collected. Hepatitis E virus ribonucleic acid was tested in 472 samples and none were positive. Anti-hepatitis E virus immunoglobin G and immunoglobin M were detected in 84 (17.3%) and 3 (0.6%) patients, respectively. Seropositivity was associated with older age, male gender, being a liver recipient, and being infected with hepatitis B virus and/or hepatitis C virus. None of the patients under the age of 30 were seropositive. Hepatitis E virus immunoglobin G prevalence was higher in the Central East and Southeast Anatolia. Eating raw meat was the only independent variable associated with hepatitis E virus seropositivity.
CONCLUSION: This is the first prevalence study of hepatitis E virus infection in solid organ recipients in Turkey. Anti-hepatitis E virus immunoglobin G prevalence was 17.3% which was higher than the previously reported rate in blood donors. Seropositivity was significantly higher in liver recipients. Despite the high antibody prevalence, none of the patients were viremic.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35040790      PMCID: PMC9128588          DOI: 10.5152/tjg.2021.21071

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.555


  14 in total

Review 1.  Hepatitis E virus: reasons for emergence in humans.

Authors:  Harini Sooryanarain; Xiang-Jin Meng
Journal:  Curr Opin Virol       Date:  2018-11-27       Impact factor: 7.090

2.  HEV seroprevalence in blood donors in Turkey by two commercial total anti-HEV Ab ELISA kits.

Authors:  Osman Yaşar; Ersin Karatayli; Güniz Cengiz; Mehtap Kızılpınar; Esra Yurdcu; Rabia Albayrak; Aysel Güven; Önder Arslan; Ceren Karahan; Barış Otlu; Hüseyin Güdücüoğlu; Selma Gökahmetoğlu; Elife Berk; Özlem Kirişci; Rüçhan Sertöz; Cihan Yurdaydin; A Mithat Bozdayi; Senem Ceren Karatayli
Journal:  J Med Virol       Date:  2019-08-21       Impact factor: 2.327

3.  The global burden of hepatitis E virus genotypes 1 and 2 in 2005.

Authors:  David B Rein; Gretchen A Stevens; Jordan Theaker; John S Wittenborn; Steven T Wiersma
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

4.  Hepatitis E virus IgG seroprevalence in HIV patients and blood donors, west-central Poland.

Authors:  Maciej Bura; Małgorzata Łagiedo; Michał Michalak; Jan Sikora; Iwona Mozer-Lisewska
Journal:  Int J Infect Dis       Date:  2017-05-30       Impact factor: 3.623

5.  Prevalence of hepatitis E virus antibodies in patients with chronic hepatitis B and chronic hepatitis C.

Authors:  A Bayram; F Eksi; M Mehli; E Sözen
Journal:  Intervirology       Date:  2007-06-15       Impact factor: 1.763

6.  A large-scale outbreak of trichinellosis caused by Trichinella britovi in Turkey.

Authors:  N Akkoc; Z Kuruuzum; S Akar; A Yuce; F Onen; N Yapar; O Ozgenc; M Turk; D Ozdemir; M Avci; Y Guruz; A M Oral; E Pozio
Journal:  Zoonoses Public Health       Date:  2008-08-14       Impact factor: 2.702

Review 7.  The impact of hepatitis E in the liver transplant setting.

Authors:  Patrick Behrendt; Eike Steinmann; Michael P Manns; Heiner Wedemeyer
Journal:  J Hepatol       Date:  2014-09-06       Impact factor: 25.083

8.  A nationwide survey of hepatitis E viral infection in French blood donors.

Authors:  Jean Michel Mansuy; Pierre Gallian; Chloé Dimeglio; Karine Saune; Catherine Arnaud; Bertrand Pelletier; Pascal Morel; Dominique Legrand; Pierre Tiberghien; Jacques Izopet
Journal:  Hepatology       Date:  2016-02-26       Impact factor: 17.425

9.  Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014/15.

Authors:  Cornelia Adlhoch; Ana Avellon; Sally A Baylis; Anna R Ciccaglione; Elisabeth Couturier; Rita de Sousa; Jevgenia Epštein; Steen Ethelberg; Mirko Faber; Ágnes Fehér; Samreen Ijaz; Heidi Lange; Zdenka Manďáková; Kassiani Mellou; Antons Mozalevskis; Ruska Rimhanen-Finne; Valentina Rizzi; Bengü Said; Lena Sundqvist; Lelia Thornton; Maria E Tosti; Wilfrid van Pelt; Esther Aspinall; Dragoslav Domanovic; Ettore Severi; Johanna Takkinen; Harry R Dalton
Journal:  J Clin Virol       Date:  2016-06-23       Impact factor: 3.168

Review 10.  Hepatitis E virus infection in Turkey: a systematic review.

Authors:  Hakan Leblebicioglu; Resat Ozaras
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-05-02       Impact factor: 3.944

View more
  1 in total

Review 1.  Seroprevalence of Hepatitis E Virus Infection in Middle Eastern Countries: A Systematic Review and Meta-Analysis.

Authors:  Fadi S Qashqari
Journal:  Medicina (Kaunas)       Date:  2022-07-06       Impact factor: 2.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.